Autres langues Eli Lilly and Company

Actions

Marché Fermé - Nyse Autres places de cotation 22:00:02 06/06/2024			Pré-ouverture 13:13:17
837,3 ^USD	+0,66 %		838,4	+0,13 %

13:02	ELI LILLY AND COMPANY : Jefferies & Co. dégrade son opinion à neutre	ZM
08:15	Le personnel de la FDA américaine signale le bénéfice limité potentiel du médicament d'Eli Lilly contre la maladie d'Alzheimer	MT

US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug	08:15
US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug	06/06
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China	06/06
Health Care Climbs on Obesity-Drug Bets - Health Care Roundup	05/06
Alphabet ficha a Anat Ashkenazi, directora financiera de Eli Lilly, para suceder a Ruth Porat	05/06
Alphabet Appoints Anat Ashkenazi as CFO	05/06
Eli Lilly's CFO Anat Ashkenazi Resigns	05/06
Eli Lilly CFO Anat Ashkenazi Resigns	05/06
Correction to Alphabet CFO Article	05/06
Eli-Lilly-Managerin wird Finanzchefin bei Google-Mutter Alphabet	05/06
Google Poaches Eli Lilly Finance Chief Ashkenazi -- Update	05/06
Alphabet : la directrice financière d'Eli Lilly recrutée	05/06
Google Poaches Eli Lilly Finance Chief Ashkenazi	05/06
Eli Lilly Chief Financial Officer Anat Ashkenazi Leaving	05/06
Alphabet names Eli Lilly executive Anat Ashkenazi as CFO	05/06
Eli Lilly finance chief to leave company	05/06
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Executive Vice President	05/06
Lilly announces departure of Anat Ashkenazi, chief financial officer	05/06
Eli Lilly and Company Announces Resignation of Anat Ashkenazi as Chief Financial Officer, Effective July 2024	05/06
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	05/06

Aucun résultat pour cette recherche

David Ricks, PDG d'Eli Lilly : Un marche de plus d'un milliard de personnes

Le 12 mars 2024 à 19:47